More than one in nine people worldwide who might benefit from a daily pill to minimize their risk of getting HIV are now taking this medicine, a research review suggests.…

When people take daily pills to minimize their chances of getting HIV, they are also more likely to get routine care like flu shots and recommended screenings for common health…

Results from a nationwide analysis on the impact of Truvada for pre-exposure prophylaxis (PrEP) showed that its use resulted in significant declines in new HIV infections in the US from 2012 to…

On July 3, 1981, this newspaper wrote about a “rare cancer” killing gay men in New York and California. Though few knew it, what followed would be a generation-defining battle:…

A smartphone app, developed at the University of Virginia School of Medicine to improve care for people living with HIV, as increased its users consistency in doctor visits and improved their health outcomes,…

A recent review of studies found that some people on PrEP engage in more risky sex. Even before PrEP hit the US market in 2012, there were fears that it would…

The Food and Drug Administration has approved the drug PrEP, also known as Truvada, for adolescents. In an anniuncement released this week, the government health agency recommended that the daily treatment be…

You pretty much know the facts when it comes to HIV, right? Well, you might be falsely confident: A study of almost 2,000 people published in BMC Public Health found that almost half had…

National Native HIV/AIDS Awareness Day (#NNHAAD)  is observed on the first day of Spring each year. The Spring Equinox is a time of equality and balance. It is a time of…

The number of people taking PrEP in the United States is steadily increasing, exceeding 77,000 in 2016, according to figures released yesterday by AIDSVu in conjunction with the 25th Conference on…